ML
Therapeutic Areas
Omeros Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Narsoplimab | HSCT-TMA | BLA Submitted |
| OMS906 | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 |
| OMIDRIA | Cataract Surgery | Marketed |
| Drug | Indication | Phase |
|---|---|---|
| Narsoplimab | HSCT-TMA | BLA Submitted |
| OMS906 | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 |
| OMIDRIA | Cataract Surgery | Marketed |